AFA Klamath belongs to the family of blue-green algae, which includes Spirulina. The queen of algae, it is the most well-balanced and complete food source known today, boasting a cocktail of 115 highly absorbent nutrients: proteins, amino acids, vitamins, minerals, trace elements, essential fatty acids and antioxidants.
AFA Klamath is only found in the wild, in one place in the world: Upper Klamath Lake in Oregon (USA). The lake is at a high altitude and enjoys exceptional sun exposure. It is fed by filtered water, rich in minerals thanks to miles of volcanic rock. Because of the exceptional climatic conditions and the fact that it is protected from pollution, these ultra-pure algae are considered to be the richest food on the planet.
AFA Klamath is believed to stimulate the production, release and migration of stem cells. These cells, mainly found in bone marrow, have tissue regenerating potential. Their stimulation gives the human body improved capacity to regenerate and repair all its organs and tissues and slow down the ageing process.
"An increase in the number of circulating stem cells one hour after an individual has ingested these algae. This property may be explained (by vitro and in vivo trials) by the presence of a ligand in the algae that modulates the expression of a signal, triggering the synthesis of new cells."
Ollier A "Using algae in dietary supplements: Uses and scientific justifications." Doctoral thesis in pharmaceutical sciences (Université de Grenoble). 2017.
American researchers have discovered a significant concentration of phenylethylamine (PEA) in AFA Klamath. This molecule is believed to boost mental activity and intellectual capacity, improving concentration, memory, energy, and physical and mental resilience.
"The phycocyanins, present in the Klamath algae extract, are powerful natural inhibitors of MAO-B, thus enabling PEA to reach the brain and perform it’s action."
Cremonte M et al., "The Effect of Experimental Supplementation with the Klamath Algae Extract Klamin on Attention-Deficit/Hyperactivity Disorder." Journal of medicinal food. 2017; 20(12): 1233-1239.
Highly concentrated in PEA (phenylethylamine), a molecule also known as the “molecule of love” or “molecule of joy”, AFA Klamath is believed to stimulate the production of happiness hormones, such as serotonin. It could thus affect mood, joyfulness and emotional well-being.
"Being PEA deeply involved in the amine modulation inside the nervous system, the increase of PEA levels might explain the higher feeling of psychological well-being in the participants."
Scoglio S et al., "Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women." Gynecological Endocrinology. 2009; 25(4): 235-240.
The antioxidants found in AFA Klamath are believed to detect toxins and heavy metals lodged in the body’s organs and tissue and to trap these harmful elements, eliminating them through the kidneys. Other algae are able to trap but not eliminate them.
"It may be possible that AFA, due to its potential antioxidant properties, improved renal functions via attenuating oxidative stress-mediated decline in GFR and renal hemodynamics."
Kuriakose G C and Kurup M G, "Evaluation of renoprotective effect of Aphanizomenon flos-aquae on treatment-induced renal dysfunction in rats." Renal failure. 2008; 30(7) : 717-725.
AFA Klamath is believed to strengthen he body’s natural defence mechanisms thanks to its detoxification capacity and antioxidant properties. The polysaccharides it contains may stimulate white blood cells, so helping the immune system to defend itself more easily and rapidly.
"A signiﬁcant body of data suggests that blue-green algae immunoenhancing properties could be useful in the adjunct treatment of various diseases involving 1) suppressed or exhausted immune system, and 2) inappropriate immune response Iing allergies, autoimmune diseases, and chronic inﬂammatory conditions."
Jensen G S, Ginsberg D I and Drapeau C, "Blue-green algae as an immuno-enhancer and biomodulator." J. Am. Nutraceutical Assoc. 2001; 3 : 24-30.
American researchers have discovered a significant concentration of phenylethylamine (PEA) in AFA Klamath. PEA is a molecule that is believed to act on our mood and to boost mental activity and intellectual capacity. In children, studies have also shown a decrease in behavioural disorders, such as hyperactivity, school-related stress and dyslexia.
"This specific extract of AFA Klamanth could help to combat ageing in neuronal function, reduce stress, anxiety and fatigue, control appetite, promote intellectual activity and improve mood."
Menvielle-Bourg J F, Vitacca A and Scoglio S, ''Klamath algae and its nutritional properties. A specific extract with neuromodulatory and neuroprotective effects.'' Phytotherapy. 2011; 9(3).
Thanks to its gamma linolenic acid, AFA Klamath is believed to help regulate appetite and the digestive system (liver and pancreas) and to facilitate intestinal transit.
" In agreement with these findings, we observed that the AFA extract has a prebiotic effect and an antioxidant activity that are not lost after thermal stress, indicating that it could regulate the gut microbiota composition."
Nuzzo D et al., "Heat-Resistant Aphanizomenon flos-aquae (AFA) Extract (Klamin®) as a Functional Ingredient in Food Strategy for Prevention of Oxidative Stress." Oxidative Medicine and Cellular Longevity 2019.
Since the Klamath extract did not show steroid-like effects on the hormonal parameters, it could be proposed as valid integration for those women seeking for alternative treatment to hormonal therapy so that to overcome many of the menopausal symptoms.
" Since the Klamath extract did not show steroid-like effects on the hormonal parameters, it could be proposed as valid integration for those women seeking for alternative treatment to hormonal therapy so that to overcome many of the menopausal symptoms. "
Genazzani, A. D., et al. "Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study." Minerva ginecologica 62.5 (2010): 381-388.